Last reviewed · How we verify
NPI-002 Intravitreal Implant
At a glance
| Generic name | NPI-002 Intravitreal Implant |
|---|---|
| Sponsor | Nacuity Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- NPI-002 Intravitreal Implant for the Delay of Cataract Progression (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |